Aytu Biopharma (AYTU) Total Debt (2014 - 2026)
Aytu Biopharma's Total Debt came in at $15.18 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 24.0% from $19.96 million a year earlier and down 24.0% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Total Debt (2014 - 2026) Analysis & Trends
Going back to fiscal Q2 2016, Aytu Biopharma's Total Debt data covers 29 quarters.
- Total Debt carries a five-year compound annual growth rate of -2.1% (FY2021 to FY2026).
- Going back by fiscal year, Total Debt was $19.96 million in FY2025 (+27.4%), $15.67 million in FY2024 (-4.2%), $16.36 million in FY2023 (-10.0%) and $18.19 million in FY2022 (+8.0%).
- The fiscal Q4 2026 figure represents the lowest quarterly Total Debt since fiscal Q2 2021.
- Year-over-year, Total Debt increased in six of the last eight quarters, with growth averaging 12.2%.
- The fastest year-over-year change in Total Debt over five years came in fiscal Q1 2026 (growth of 52.9%), and the weakest in fiscal Q3 2024 (a decline of 33.4%).
- Business Quant data shows AYTU's Total Debt at $19.96 million (Q3 2026), $19.07 million (Q2 2026) and $25.32 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 49.50 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 44.65 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 80.90 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 53.78 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | -11.96 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 54.01 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 26.23 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 62.67 Bn |
| 10 | Aytu Biopharma | 22.17 Mn | -93.50 Mn | 10.41 Mn | 17.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.03 Mn |
| Mar 31, 2026 | 21.82 Mn |
| Dec 31, 2025 | 20.93 Mn |
| Sep 30, 2025 | 27.18 Mn |
| Jun 30, 2025 | 21.82 Mn |
| Mar 31, 2025 | 21.42 Mn |
| Dec 31, 2024 | 15.85 Mn |
| Sep 30, 2024 | 16.56 Mn |
| Jun 30, 2024 | 17.52 Mn |
| Mar 31, 2024 | 16.72 Mn |
| Dec 31, 2023 | 16.04 Mn |
| Sep 30, 2023 | 16.12 Mn |
| Jun 30, 2023 | 16.36 Mn |
| Mar 31, 2023 | 25.09 Mn |
| Dec 31, 2022 | 22.05 Mn |
| Sep 30, 2022 | 22.57 Mn |
| Jun 30, 2022 | 18.19 Mn |
| Mar 31, 2022 | 17.65 Mn |
| Dec 31, 2021 | 23.68 Mn |
| Sep 30, 2021 | 21.18 Mn |
API Access
Aytu Biopharma Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();